Cvs Wild Berry Antacid Chews

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are advised to chew and swallow 1 to 2 chewable tablets every 2 to 4 hours as needed for symptom relief. The total daily dosage should not exceed 5 chewable tablets within a 24-hour period.

For children under 12 years of age, it is recommended to consult a healthcare professional prior to administration to determine appropriate dosing and safety.

Contraindications

The product should not be used at the maximum dosage for more than 2 weeks unless advised and supervised by a physician. This limitation is in place to mitigate potential risks associated with prolonged high-dose use. No other contraindications have been specified in the provided data.

Warnings and Precautions

Patients with a history of allergic reactions to this product or any of its ingredients should not use it. This contraindication is critical to prevent severe allergic responses.

It is advised that the maximum dosage not be exceeded for a duration longer than 2 weeks unless specifically directed and monitored by a physician. Adhering to this guideline is essential to mitigate the risk of potential adverse effects associated with prolonged use.

Currently, there are no specific recommendations for laboratory tests associated with the safe use of this product. Healthcare professionals should remain vigilant and consider individual patient circumstances when prescribing.

In the event of any concerning symptoms or adverse reactions, patients are encouraged to seek immediate medical attention. Additionally, if any unexpected side effects occur, it is imperative for patients to discontinue use and consult their healthcare provider for further guidance.

Side Effects

Patients should be aware that the use of this product is contraindicated in individuals who have a history of allergic reactions to the product or any of its ingredients. This warning is critical to prevent serious allergic responses that may occur upon administration.

In clinical trials and postmarketing experiences, no additional adverse reactions have been reported beyond those associated with allergic reactions. Therefore, careful screening for prior allergic history is essential before initiating treatment with this product to ensure patient safety.

Drug Interactions

Antacids have the potential to interact with certain prescription medications. It is advisable for healthcare professionals to assess the specific medications being prescribed alongside antacids to determine any possible interactions.

Currently, there is no additional information available regarding drug interactions or interactions with laboratory tests. Therefore, monitoring and dosage adjustments should be guided by clinical judgment and the specific context of the patient's treatment regimen.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Wild Berry Antacid Chews (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 to 2 chewable tablets taken every 2 to 4 hours as needed, with a maximum of 5 chewable tablets in a 24-hour period.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise. In the event of suspected overdosage, it is recommended to initiate supportive care and symptomatic treatment as necessary.

Healthcare providers should consider contacting a poison control center for guidance on management strategies tailored to the specific situation. Continuous assessment of the patient's clinical status is essential to ensure appropriate interventions are implemented promptly.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. The use of this product may result in constipation. No relevant information regarding nonclinical toxicology or animal pharmacology and toxicology is available in the insert.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion.

Patients should be informed not to exceed the maximum dosage for more than two weeks unless directed by a physician. It is important for patients to understand the potential for constipation as a side effect when using this product.

Additionally, healthcare providers should encourage patients to consult with a doctor or pharmacist before using this product if they are currently taking any prescription medications. This is particularly crucial as antacids may interact with certain prescription drugs, and professional guidance can help mitigate any risks associated with such interactions.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored in a dry place at a temperature range of 20° to 25°C (68° to 77°F). Proper storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cvs Wild Berry Antacid Chews, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)